LAS VEGAS, April 13 /PRNewswire-FirstCall/ -- Millenium Holding Group, Inc. (BULLETIN BOARD: MNHG) , today announced that it has acquired an exclusive 15-year license to develop, manufacture and distribute a patented ultrasonic probe. The applications, which will be the focus of the technology, will be in the cardiology and radiology markets. The acquisition of the license is a strategic move by Millenium Holding Group, Inc. to enter the highly profitable medical devices industry through the acquisition of both therapeutic and diagnostic technologies. It is the intention of the Company to focus its core business on the medical device industry. The acquisition of this license will allow the Company to develop additional products using the protocol from the source patent.
“The acquisition of the probe is especially interesting for use in cardiology and vascular surgery,” said Richard Ham, CEO/President of Millenium Holding Group, Inc. “The Company anticipates bringing on new management in the medical devices sector to develop this application as well as to focus the direction of the Company in the medical device industry.”
The Company looks forward to the acquisition of additional medical device products, companies and opportunities.
Forward-Looking Statements.
This Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Forward-looking statements usually contain the words “estimate,” “anticipate,” “believe,” “plan,” “expect,” or similar expressions, and are subject to numerous known and unknown risks and uncertainties. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this Release, including the above matters and in the Company’s SEC filings. These risks and uncertainties could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements.
Media Contact: Barry Forward Vosnuevo Communications Inc. Tel: (866) 676-8386 Email: media@vosnuevo.com
Millenium Holding Group, Inc.
CONTACT: Barry Forward of Vosnuevo Communications, +1-866-676-8386, ormedia@vosnuevo.com, for Millenium Holding Group
Web site: http://www.tangent3.com/
